Skip to content
 HR Energy
Site Tools
Narrow screen resolution Wide screen resolution Auto adjust screen size Increase font size Decrease font size Default font size
You are here: Home arrow News arrow Health
Health
American Diabetes Month Brings Awareness to Growing Health Care Crisis E-mail
Monday, 05 November 2007
The American Diabetes Association’s (ADA) American Diabetes Month brings to light the fastest growing health care crisis of the 21st century: diabetes.  Nearly 75 million Americans have diabetes or are at risk of developing type 2 diabetes. Every week in November, the ADA will highlight the “Many Faces of Diabetes.”
 
GRACE Study Involves Record Number of Women, Minorities E-mail
Monday, 05 November 2007
An innovative study is comparing how HIV-positive women respond differently to medication than their male counterparts. The Gender, Race and Clinical Experience (GRACE) study was launched last fall to compare how women and men respond differently to the drug Prezista darunavir) and antiretroviral agents. The groundbreaking study is also exploring racial differences in treatment outcomes.  Click to continue at BlackAIDS.org
 
Sudden infant death syndrome: Collaborative approach needed E-mail
Friday, 02 November 2007
Tackling sudden infant death syndrome (SIDS) requires a collaborative effort that engages health professionals and policymakers, researchers, medical examiners and coroners, grief counsellors and family support agencies, and most of all families and communities.
 
New genetic variant associated with prostate cancer in African-Americans E-mail
Thursday, 01 November 2007
Two tiny genetic variations may provide the best clues yet for finding more precise ways to estimate prostate cancer risk and improve screening and early detection for men of African descent...
 
Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension E-mail
Thursday, 01 November 2007
Forest Laboratories, Inc. today announced the results of a double-blind, randomized, placebo-controlled clinical trial which demonstrated that nebivolol significantly reduced sitting diastolic and systolic blood pressure used as monotherapy among African-American patients with stage I-II hypertension. The study also found that nebivolol was well tolerated in comparison to placebo, with a low incidence of traditional beta blocker side effects, such as fatigue, sexual dysfunction, and depression.
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 11 - 15 of 58